Skip to main content
SpringerLink
Log in

Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study was to analyze the long-term survival and the various prognostic factors that influence overall survival in patients undergoing pancreaticoduodenectomy (PD) with non-pancreatic periampullary carcinomas.

Methods

A retrospective analysis of consecutive patients diagnosed with non-pancreatic periampullary carcinomas who underwent PD at a tertiary cancer center was performed. Univariate analysis of various prognostic factors influencing the disease-free survival (DFS) was performed using log-rank test. Factors identified to be significant in univariate analysis were included in the multivariate analysis, which was performed using the Cox proportional hazard model. The survival estimates were calculated by life-table method. Statistical significance was considered when p value was <0.05. The SPSS v16.0.1 software was used for statistical analysis.

Results

Between 1995 and 2010, 78 patients underwent PD with or without (Whipple’s operation) pylorus preservation for non-pancreatic periampullary adenocarcinomas. Of these, eight patients received adjuvant chemotherapy. The most common subsite was ampulla (60 patients), followed by the second part duodenum (11 patients), and distal common bile duct (7 patients). The median duration of follow-up of all patients in this study was 50 months. The recurrence rate was 39.7 %. The 5-year disease-free survival and overall survival was 57 %. Patients without nodal metastasis had a non-significant trend towards better 5-year disease-free survival when compared to those with nodal metastasis (64 vs 45 %, p = 0.11). On multivariate analysis, it was found that male gender (p = 0.05) and presence of lymphovascular invasion (p = 0.04) predicted a significantly poor 5-year disease-free survival.

Conclusion

Periampullary carcinomas have a favorable prognosis after surgery. Male gender and presence of lymphovascular invasion are independent prognostic factors in patients diagnosed with non-pancreatic periampullary carcinomas who underwent PD in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Samiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543–55.

    Article  Google Scholar 

  2. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg. 1987;206:358–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Warren KW, Choe DS, Plaza J, Relihan M. Results of radical resection for periampullary cancer. Ann Surg. 1975;181:534–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chan C, Herrera MF, de la Garza L, Quintanilla-Martinez L, Vargas-Vorackova F, Richaud-Patín Y, et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg. 1995;222(5):632–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Morris–Stiff G, Alabraba E, Tan YM, Shapey I, Bhati C, Tanniere P, et al. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. EJSO. 2009;35:746–50. doi:10.1016/j.ejso.2008.10.010.

    Article  PubMed  Google Scholar 

  6. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 7th edition. 2010.

  7. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.

    Article  PubMed  Google Scholar 

  8. Kim RD, Kundhal PS, McGilvray ID, Cattral MS, Taylor B, Langer B, Grant DR, Zogopoulos G, Shah SA, Greig PD, Gallinger S. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg. 2006;202(1):112–9.

    Article  PubMed  Google Scholar 

  9. Jean HK, Jeekel J, Sahmoud T, Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cooperative group. Ann Surg. 1999;230(6):776–84.

    Article  Google Scholar 

  10. Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, Wan YL. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007;31(1):137–43 .discussion 144-6

    Article  PubMed  Google Scholar 

  11. Ioannis H, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991–7. doi:10.1245/s10434-009-0883-9.

    Article  Google Scholar 

  12. Charles JY, Sohn TA, Cameron JL, Hruban RH, Uiemoe KD, Pitt HA. Periampullary adenocarcinoma analysis of 5-year survivors. Ann Surg. 1998;227(6):821–31.

    Article  Google Scholar 

  13. Di Giorgio A, Alfieri S, Rotondi F, Prete F, Di Miceli D, Ridolfini MP, Rosa F, Covino M, Doglietto GB. Pancreatoduodenectomy for tumors of Vater’s ampulla: report on 94 consecutive patients. World J Surg. 2005;29(4):513–8.

    Article  PubMed  Google Scholar 

  14. Bucher P, Chassot G, Durmishi Y, Ris F, Morel P. Long-term results of surgical treatment of Vater’s ampulla neoplasms. Hepato-Gastroenterology. 2007;54(76):1239–42.

    PubMed  Google Scholar 

  15. George AP, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N, Choti MA, Wolfgang CL, Schulick RD. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19(6):1928–35. doi:10.1245/s10434-011-2168-3.

    Article  Google Scholar 

  16. Feng JF, Zhou XM, Mao WM. Prognostic analysis of carcinoma of the ampulla of Vater: pancreaticoduodenectomy versus local resection. Hippkratia. 2012;16(1):23–8.

    Google Scholar 

  17. Wang CH, Mo LR, Lin RC, Kuo JJ, Chang KK, Lin YW, Yang DM, Yau MP, Cho CY. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma. Hepato-Gastroenterology. 2004;51(59):1495–9.

    PubMed  Google Scholar 

  18. Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepato-Biliary-Pancreat Surg. 2008;15:41–54. doi:10.1007/s00534-007-1279-5.

    Article  Google Scholar 

  19. Bettschart V, Rahman MQ, Engelken FJ, Madhavan KK, Parks RW, Garden OJ. Presentation, treatment and outcome in patients with ampullary tumours. Br J Surg. 2004;91(12):1600–7.

    Article  CAS  PubMed  Google Scholar 

  20. Sakata J, Shirai Y, Wakai T, Yokoyama N, Sakata E, Akazawa K, Hatakeyama K. Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. Eur J Surg Oncol. 2007;33(3):346–51.

    Article  CAS  PubMed  Google Scholar 

  21. Fritz K, Jacob D, Bahra M, Pelzer U, Puhl G, Krannich A, Andreou A, Gül S, Guckelberger O. Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenectomy. HPB Surg. 2014;2014(2014):Article ID 970234. doi:10.1155/2014/970234.8 pages

    Google Scholar 

  22. Lindell G, Borch K, Tingstedt B, Enell EL, Ihse I. Management of cancer of the ampulla of Vater: does local resection play a role? Dig Surg. 2003;20:511–5.

    Article  PubMed  Google Scholar 

  23. Joon SP, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR. Factors influencing recurrence after curative resection for ampulla of vater carcinoma. J Surg Oncol. 2007;95:286–90.

    Article  Google Scholar 

  24. Yeo CJ, Cameron JL, Lillemoe KD et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–68.

  25. Branum GD, Pappas TN, Meyers WC. (1996) The management of tumors of the ampulla of Vater by local resection. Ann Surg. 1996;224:621–7.

  26. Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, Rosato EF. (2000) Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys. 2000;47(4):945–53.

  27. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95(8):1685–95.

  28. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147–56. doi:10.1001/jama.2012.7352.

  29. Narang AK, Miller RC, Hsu CC, Bhatia S, Pawlik TM, Laheru D, Hruban RH, Zhou J, Winter JM, Haddock MG, Donohue JH, Schulick RD, Wolfgang CL, Cameron JL, Herman JM. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiat Oncol. 2011;6:126. doi:10.1186/1748-717X-6-126.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Cancer Institute (WIA), Dr. S. Krishnamurthy Campus, No.18, Sardar Patel road, Guindy, Chenai, 600036, India

    Bhanu Jayanand Sunil & Ramakrishnan A Seshadri

  2. Department of Surgical Oncology, Sri Ramachandra Medical University, Chennai, India

    S. Gouthaman

  3. Department of Biostatistics, Cancer Institute (WIA), Chennai, India

    Rama Ranganathan

Authors
  1. Bhanu Jayanand Sunil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ramakrishnan A Seshadri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Gouthaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rama Ranganathan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ramakrishnan A Seshadri.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sunil, B.J., Seshadri, R.A., Gouthaman, S. et al. Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma. J Gastrointest Canc 48, 13–19 (2017). https://doi.org/10.1007/s12029-016-9863-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-016-9863-z

Keywords

Search

Navigation